Antibody-based drugs now rival or surpass the small-molecule drugs in terms of effectivity, specificity, minimal side effects, number of ongoing […]
×
Recent Posts
- Trianni, Inc. and San Diego Biomedical Research Institute Announce License Agreement for the Trianni Mouse®
- Trianni, Inc. Announces Issuance of Patent in Japan
- Trianni, Inc. and MacroGenics, Inc. Announce License Agreement
- Trianni, Inc. and Simon Fraser University Announce Licensing Agreement for The Trianni Mouse™
- Gilead Enters Licensing Agreement With Trianni for Use of Trianni Transgenic Human Monoclonal Antibody Discovery Platform
Recent Comments